Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism MIEN1 inhibitors(migration and invasion enhancer 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | US | 05 Apr 2024 | |
Prostatic Cancer | Preclinical | US | 05 Apr 2024 |